—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Intuitive Surgical Inc (ISRG) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Company snapshot — Intuitive Surgical Inc

ISRG in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Intuitive Surgical designs, builds and sells robotic systems that let surgeons carry out minimally invasive operations through small incisions. Its main product, the da Vinci system, guides instruments during surgery, and it also makes the Ion system for lung biopsies reached through the airway. Revenue comes first from the equipment, then from the instruments, service contracts and training hospitals buy on an ongoing basis. It sells through its own direct sales teams and is based in Sunnyvale, California.
Where it sits in the stack
Intuitive Surgical carries no seat in Rubin, our AI hardware build-out index; it sits instead in the HALO Growth 100, our growth index outside the megacaps, inside the Surgical, Med Devices & Animal Health sleeve — regulated devices with long replacement cycles rather than build-out capital equipment.
Who it is priced against
Closelooknet's peer group for this sleeve groups it with Globus Medical, IDEXX Laboratories, Sonova, Stryker, Sartorius, DexCom and Insulet, businesses built on robotic surgery, glucose sensors, hearing devices and animal-health platforms behind regulated moats. The market also names Medtronic as a comparable in robotic and surgical systems.
Why Closelooknet tracks it
It holds seats in the Nasdaq-100 and the HALO Growth 100; Closelooknet's score shows the balance sheet module as strongest and momentum as weakest. The diary has quoted it once, in a dossier on agentic software, noting that it is embedding AI into robotic surgery.
What the diary watches
The diary watches whether the momentum reading moves off its current low point and whether the AI features described in robotic surgery move from a stated ambition into something hospitals actually buy.

Intuitive Surgical Inc (ISRG) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 56/100 composite (momentum 21, quality 75, valuation 23) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: ISRG news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelooknet reading that exists for ISRG, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against ISRG on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
ISRG+1.4%+3.0%+9.4%+0.1%
Surgical, Med Devices & Animal Health+0.2%+1.4%−3.7%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 2.8 pts ahead on the week, 17.0 pts ahead on the month; against its Surgical, Med Devices & Animal Health sleeve 13.1 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Dividends and capital return no distribution in twelve months · buybacks 2.30 bn USD in FY2025

Dividends and capital return

What ISRG pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 2.30 bn USD 1.6% of today's market value
  • Share count +0.2% in FY2025 788 m USD of stock-based compensation in the year
  • Capital returned 2.30 bn USD · 92% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

How it trades on rate days beta 0.34 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How ISRG has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.34 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Intuitive Surgical Inc moved 0.34% on average · correlation 0.09 · higher than 34% of US names
  • Beta, last 3 months 0.49 about the same as over the year
  • On the 10 worst bond days −0.61% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +0.31% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Intuitive Surgical Inc (ISRG)?

Intuitive Surgical Inc trades as ISRG on the US exchange and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is ISRG in a Closelooknet index?

Yes — Intuitive Surgical Inc is a constituent of HALO Growth 100, as of 2026-09-26.

What is Intuitive Surgical Inc's Closelooknet composite score?

56 out of 100, with momentum 21, quality 75 and valuation 23 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does ISRG trade against its moving averages?

Stochastic turned down: Its stochastic crossed down from overbought (%K 92.7 under %D 94.7) 2 sessions ago — momentum is cooling. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is ISRG doing against its Closelooknet index?

Over the past month Intuitive Surgical Inc is +9.4% against −7.6% for the HALO Growth 100 — 17.0 points ahead of its index, as of 2026-09-25. Its Surgical, Med Devices & Animal Health sleeve is −3.7% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Intuitive Surgical Inc do?

Intuitive Surgical designs, builds and sells robotic systems that let surgeons carry out minimally invasive operations through small incisions. Its main product, the da Vinci system, guides instruments during surgery, and it also makes the Ion system for lung biopsies reached through the airway. Revenue comes first from the equipment, then from the instruments, service contracts and training hospitals buy on an ongoing basis. Closelooknet's peer group for this sleeve groups it with Globus Medical, IDEXX Laboratories, Sonova, Stryker, Sartorius, DexCom and Insulet, businesses built on robotic surgery, glucose sensors, hearing devices and animal-health platforms behind regulated moats. The market also names Medtronic as a comparable in robotic and surgical systems.

Where does Intuitive Surgical Inc sit in the AI build-out?

Intuitive Surgical carries no seat in Rubin, our AI hardware build-out index; it sits instead in the HALO Growth 100, our growth index outside the megacaps, inside the Surgical, Med Devices & Animal Health sleeve — regulated devices with long replacement cycles rather than build-out capital equipment. It holds seats in the Nasdaq-100 and the HALO Growth 100; Closelooknet's score shows the balance sheet module as strongest and momentum as weakest. The diary has quoted it once, in a dossier on agentic software, noting that it is embedding AI into robotic surgery.

Does Intuitive Surgical Inc pay a dividend?

No cash distribution shows in Intuitive Surgical Inc’s price series over the last three years. In fiscal 2025 the company bought back 2.30 bn USD of its own shares, 92% of that year’s free cash flow. The share count rose 0.2% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

How does Intuitive Surgical Inc trade when bond yields rise?

Over the past year Intuitive Surgical Inc had a beta of 0.34 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 34% of US names. On the 10 sessions in which long bonds fell most it moved −0.61% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Intuitive Surgical Inc?

Intuitive Surgical Inc appears in 1 Closelooknet piece, most recently Dossier: Agentic Application Software: The SaaSpocalypse Map (2026-02-27). What Closelooknet said most recently: But AI agents in clinical workflows are coming: Tempus AI is building AI-native oncology tools, Intuitive Surgical is embedding AI in robotic surgery, and Veeva owns the regulatory data infrastructure for life sciences. (Dossier, 2026-02-27). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for ISRG, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Mentioned on Closelooknet 1 piece · newest: Dossier, “Agentic Application Software: The SaaSpocalypse Map” (2026-02-27)

Mentioned on Closelooknet

Where ISRG appears in the diary — 1 piece, newest first. Every link is our own writing.

Go deeper

Long reads

  • Agentic Application Software: The SaaSpocalypse MapDossier · $39 · 27 Feb 2026But AI agents in clinical workflows are coming: Tempus AI is building AI-native oncology tools, Intuitive Surgical is embedding AI in robotic surgery, and Veeva owns the regulatory data infrastructure for life sciences.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.